Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Mar-13 9:24 AM View:  | Progenics Pharmaceuticals I... (PGNX) | 27-Mar-13 | Market Purchase (Planned) | 650 | $5.32 | $3,458.00 | < 1% 160.49K to 161.14K | (8%) |
| 28-Feb-13 5:24 PM View: | Progenics Pharmaceuticals I... (PGNX) | 27-Feb-13 | Market Purchase (Planned) | 1,262 | $2.72 | $3,434.45 | < 1% 159.23K to 160.49K | 80% |
| 23-Jan-13 9:59 AM View: | Progenics Pharmaceuticals I... (PGNX) | 22-Jan-13 | Market Purchase (Planned) | 1,215 | $2.82 | $3,429.45 | < 1% 158.01K to 159.23K | 74% |
| 26-Dec-12 1:05 PM View: | Progenics Pharmaceuticals I... (PGNX) | 26-Dec-12 | Market Purchase (Planned) | 1,142 | $3.01 | $3,437.42 | < 1% 156.87K to 158.01K | 63% |
| 30-Nov-12 12:07 PM View: | Progenics Pharmaceuticals I... (PGNX) | 28-Nov-12 | Market Purchase (Planned) | 1,607 | $2.13 | $3,418.58 | 1% 155.26K to 156.87K | 130% |
| 20-Nov-12 1:41 PM View: | Progenics Pharmaceuticals I... (PGNX) | 19-Nov-12 | Market Purchase | 11,800 | $1.96 | $23,104.40 | 8% 143.47K to 155.26K | 150% |
| 19-Nov-12 1:50 PM View: | Progenics Pharmaceuticals I... (PGNX) | 16-Nov-12 | Market Purchase | 49,793 | $1.82 | $90,722.80 | 53% 93.67K to 143.47K | 169% |
| 16-Nov-12 1:54 PM View: | Progenics Pharmaceuticals I... (PGNX) | 15-Nov-12 | Market Purchase | 48,833 | $1.69 | $82,332.40 | 109% 44.84K to 93.67K | 191% |
| 25-Oct-12 11:34 AM View: | Progenics Pharmaceuticals I... (PGNX) | 24-Oct-12 | Market Purchase (Planned) | 1,162 | $2.95 | $3,433.71 | 3% 43.68K to 44.84K | 66% |
| 27-Sep-12 3:14 PM View: | Progenics Pharmaceuticals I... (PGNX) | 26-Sep-12 | Market Purchase (Planned) | 1,036 | $3.32 | $3,439.52 | 2% 42.64K to 43.68K | 48% |
| 23-Aug-12 9:44 AM View: | Progenics Pharmaceuticals I... (PGNX) | 22-Aug-12 | Market Purchase (Planned) | 815 | $4.23 | $3,450.71 | 2% 41.83K to 42.64K | 16% |
| 26-Jul-12 11:42 AM View: | Progenics Pharmaceuticals I... (PGNX) | 25-Jul-12 | Market Purchase (Planned) | 346 | $10.04 | $3,472.80 | < 1% 41.48K to 41.83K | (51%) |
| 29-Jun-12 9:15 AM View: | Progenics Pharmaceuticals I... (PGNX) | 27-Jun-12 | Market Purchase (Planned) | 375 | $9.27 | $3,477.33 | < 1% 41.1K to 41.48K | (47%) |
| 24-May-12 12:38 PM View: | Progenics Pharmaceuticals I... (PGNX) | 23-May-12 | Market Purchase (Planned) | 445 | $7.81 | $3,475.45 | 1% 40.66K to 41.1K | (37%) |
| 27-Apr-12 9:23 AM View: | Progenics Pharmaceuticals I... (PGNX) | 25-Apr-12 | Market Purchase (Planned) | 348 | $10.07 | $3,506.00 | < 1% 40.31K to 40.66K | (51%) |
| 29-Mar-12 3:12 PM View: | Progenics Pharmaceuticals I... (PGNX) | 28-Mar-12 | Market Purchase (Planned) | 343 | $10.13 | $3,475.14 | < 1% 39.97K to 40.31K | (52%) |
| 23-Feb-12 9:28 AM View: | Progenics Pharmaceuticals I... (PGNX) | 22-Feb-12 | Market Purchase (Planned) | 369 | $9.41 | $3,473.78 | < 1% 39.6K to 39.97K | (48%) |
| 26-Jan-12 10:05 AM View: | Progenics Pharmaceuticals I... (PGNX) | 25-Jan-12 | Market Purchase (Planned) | 364 | $9.53 | $3,470.42 | < 1% 39.24K to 39.6K | (49%) |
| 12-Jan-12 1:16 PM View: | Progenics Pharmaceuticals I... (PGNX) | 11-Jan-12 | Market Purchase (Planned) | 391 | $8.87 | $3,466.26 | 1% 38.84K to 39.24K | (45%) |
| 28-Nov-11 2:18 PM View: | Progenics Pharmaceuticals I... (PGNX) | 23-Nov-11 | Market Sale (Planned) | 634 | $5.45 | $3,455.30 | 2% 37.68K to 38.31K | (10%) |
| 12-Jan-12 1:16 PM View: | Progenics Pharmaceuticals I... (PGNX) | 26-Oct-11 | Market Purchase (Planned) | 532 | $6.52 | $3,467.13 | 1% 37.68K to 38.21K | (25%) |
| 04-Oct-11 5:20 PM View: | Progenics Pharmaceuticals I... (PGNX) | 03-Oct-11 | Payment of Exercise | 4,666 | $5.44 | $25,383.00 | (11%) 42.34K to 37.68K | 10% |
| 04-Oct-11 5:20 PM View: | Progenics Pharmaceuticals I... (PGNX) | 03-Oct-11 | Option Exercise | 5,124 | $4.62 | $23,693.40 | 14% 37.22K to 42.34K | |
| 28-Sep-11 4:55 PM View: | Progenics Pharmaceuticals I... (PGNX) | 28-Sep-11 | Market Purchase (Planned) | 542 | $6.39 | $3,463.23 | 1% 36.49K to 37.03K | (23%) |
| 25-Aug-11 9:31 AM View: | Progenics Pharmaceuticals I... (PGNX) | 24-Aug-11 | Market Purchase (Planned) | 571 | $6.08 | $3,471.68 | 2% 35.92K to 36.49K | (20%) |
| 28-Jul-11 5:06 PM View: | Progenics Pharmaceuticals I... (PGNX) | 27-Jul-11 | Market Purchase (Planned) | 567 | $6.12 | $3,471.74 | 2% 35.35K to 35.92K | (20%) |
| 06-Jul-11 6:49 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-11 | Payment of Exercise | 16,905 | $7.40 | $125,097.00 | (32%) 52.25K to 35.35K | 34% |
| 06-Jul-11 6:49 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-11 | Option Exercise | 20,032 | $5.46 | $109,375.00 | 62% 32.22K to 52.25K | |
| 24-Jun-11 10:07 AM View: | Progenics Pharmaceuticals I... (PGNX) | 22-Jun-11 | Market Purchase (Planned) | 490 | $7.08 | $3,469.20 | 2% 31.43K to 31.92K | (31%) |
| 26-May-11 3:15 PM View: | Progenics Pharmaceuticals I... (PGNX) | 25-May-11 | Market Purchase (Planned) | 486 | $7.13 | $3,465.18 | 2% 30.95K to 31.43K | (31%) |
| 27-Apr-11 4:05 PM View: | Progenics Pharmaceuticals I... (PGNX) | 27-Apr-11 | Market Purchase (Planned) | 479 | $7.24 | $3,467.96 | 2% 30.47K to 30.95K | (32%) |
| 05-Apr-11 9:51 AM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Apr-11 | Payment of Exercise | 3,550 | $6.29 | $22,329.50 | (10%) 34.02K to 30.47K | 22% |
| 05-Apr-11 9:51 AM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Apr-11 | Option Exercise | 4,022 | $5.05 | $20,311.10 | 13% 30.0K to 34.02K | |
| 05-Jan-11 4:29 PM View: | Progenics Pharmaceuticals I... (PGNX) | 03-Jan-11 | Payment of Exercise | 4,014 | $5.68 | $22,799.50 | (12%) 33.77K to 29.75K | 14% |
| 05-Jan-11 4:29 PM View: | Progenics Pharmaceuticals I... (PGNX) | 03-Jan-11 | Option Exercise | 4,377 | $4.83 | $21,132.20 | 15% 29.39K to 33.77K | |
| 04-Oct-10 5:39 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Oct-10 | Payment of Exercise | 15,972 | $5.08 | $81,137.80 | (35%) 45.16K to 29.19K | 5% |
| 04-Oct-10 5:39 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Oct-10 | Option Exercise | 17,545 | $4.32 | $75,759.30 | 64% 27.61K to 45.16K | |
| 06-Jul-10 2:25 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-10 | Payment of Exercise | 4,108 | $5.35 | $21,977.80 | (13%) 31.5K to 27.39K | 9% |
| 06-Jul-10 2:25 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-10 | Option Exercise | 4,575 | $4.44 | $20,313.00 | 17% 26.93K to 31.5K | |
| 24-Jun-10 10:20 AM View: | Progenics Pharmaceuticals I... (PGNX) | 22-Jun-10 | Market Sale | 2,328 | $5.66 | $13,185.80 | (8%) 29.02K to 26.69K | 14% |
| 05-Apr-10 4:50 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Apr-10 | Payment of Exercise | 3,913 | $5.36 | $20,973.70 | (12%) 32.93K to 29.02K | 10% |
| 05-Apr-10 4:50 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Apr-10 | Option Exercise | 4,300 | $4.56 | $19,590.80 | 15% 28.63K to 32.93K | |
| 18-Mar-10 3:53 PM View: | Progenics Pharmaceuticals I... (PGNX) | 18-Mar-10 | Market Sale (Planned) | 2,165 | $5.33 | $11,539.50 | (7%) 30.59K to 28.42K | 9% |
| 06-Jan-10 3:10 PM View: | Progenics Pharmaceuticals I... (PGNX) | 04-Jan-10 | Payment of Exercise | 4,295 | $4.45 | $19,112.80 | (12%) 34.88K to 30.59K | (9%) |
| 06-Jan-10 3:10 PM View: | Progenics Pharmaceuticals I... (PGNX) | 04-Jan-10 | Option Exercise | 4,720 | $3.78 | $17,855.80 | 16% 30.16K to 34.88K | |
| 05-Oct-09 4:04 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Oct-09 | Payment of Exercise | 3,639 | $5.01 | $18,231.40 | (11%) 33.55K to 29.91K | 3% |
| 05-Oct-09 4:04 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Oct-09 | Option Exercise | 3,999 | $4.26 | $17,031.70 | 14% 29.55K to 33.55K | |
| 06-Jul-09 2:53 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-09 | Payment of Exercise | 12,018 | $5.33 | $64,055.90 | (29%) 41.36K to 29.34K | 10% |
| 06-Jul-09 2:53 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-09 | Option Exercise | 13,207 | $5.33 | $70,393.30 | 47% 28.16K to 41.36K | (10%) |
| 03-Apr-09 4:32 PM View: | Progenics Pharmaceuticals I... (PGNX) | 01-Apr-09 | Payment of Exercise | 2,893 | $6.65 | $19,238.50 | (9%) 30.84K to 27.94K | 31% |